Executive Team

Since our inception in 1976, PRA has amassed a level of expertise that has enabled us to conduct complex global clinical trials across all therapeutic areas, and provide outsourced clinical services across all phases of pharmaceutical and biotech drug development. 

Our teams of experts are the core of the company promoting our forward-thinking culture with: innovation, continuous attention to detail, constant quality improvement and a high priority approach to safety and time-lines. Our pioneering mind-set and specialist knowledge can make an enormous difference to your study

 

Colin Shannon

President and
Chief Executive Officer

 

 

Linda Baddour

Executive Vice President and
Chief Financial Officer

 

David W. Dockhorn 

Executive Vice President and
Compliance Officer

Willem Jan Drijfhout

Executive Vice President
Early Development Services

 

Tami Klerr-Naivar  

Executive Vice President 
Business Development

 

 

 

 

 

 

 

 

 

 

 

Sean Leech 

Executive Vice President 
Product Registration

 

Steve Powell

Executive Vice President
Clinical Informatics and Late Phase Services

Andrew Strayer

Executive Vice President
Product Registration

 

Kent Thoelke

Executive Vice President
Scientific & Medical Affairs